China Diagnostic Reagent Company Goes Global
This article was originally published in PharmAsia News
Executive Summary
Shanghai Kehua Bio-engineering Co., Ltd., a major diagnostic reagent manufacturer in China, announced that its 42 diagnostic reagents and three medical devices have received the CE marking, which means it can enter the EU market. The company will be setting up a joint venture with leading diagnostic equipment manufacturer Bio Merieux. The worldwide diagnostic reagent business is worth $20 billion, and the 4-billion-yuan China market is expected to grow at 15-20 percent annually over the next five years. The business potential is attracting MNCs, which will intensify the competition for local players greatly limited by size, product varieties and poor development. (Click here for more - Chinese Language)